iStent inject Trabecular Micro-Bypass System

Glaukos

The iStent inject Trabecular Micro-Bypass System entails an injector system preloaded with two micro-scale stents that the surgeon places sequentially through a single corneal entry point directly into two locations within the trabecular meshwork to restore the natural, physiological outflow.

At-a-Glance
  • Material: Surgical-grade Nonferromagnetic Titanium with heparin coating
  • Each stent measures 0.36 mm in height and 0.23 mm in width (about one-third the size of the first-generation iStent)
  • Preservation of the trabecular meshwork ensures a natural episcleral back pressure of 8-11 mm Hg with minimal risk of hypotony
  • Prior to premarket approval (PMA) from the FDA, more than 30,000 iStent injects had been implanted in the European Union, Armenia, Australia, Brazil, Canada, Hong Kong, Singapore and South Africa

Details

FDA

Yes

CE Mark

Yes

Classification

Ab interno

Indication

For the reduction of IOP in adult patients with mild-to-moderate primary open-angle glaucoma currently treated with ocular hypotensive medication

Mechanism of Action

Enable aqueous outflow from the anterior chamber into Schlemm canal

Usage

Treatment of mild to moderate glaucoma during cataract surgery

From Your Peers

Show More

Company Information

Contact the company for additional information, availability, or pricing:

Glaukos

glaukos.com

229 Avenida Fabricante

San Clemente, CA 92672